>
|
 |
Ʈ Űγ, Ǿǰû ǰ㰡
|
|
|
|
|
|
|
|
 | 㷺Űγ (=Ʈ ) |
۸ ؼ ڣ
Ʈ 2( ð) Ǿǰû(EMA, European Medicines Agency) ڷγ19 ü ġ Űγ(߸ CT-P59, и ״ܺRegdanvimab) ϴ ǰ ϱ ߴٰ 3 .
̹ 2 24Ϻ(ð) Ѹ ʹ , Űγ ñ 濪籹 EMA ǰ㰡 α(Compassionate Use Program) ֵ EMA ڹȸ(CHMP) Ҽ Űγ ο ǰ Ѵٴ .
̹ ڷγ19 ߵ ȯ Կ 豺 ȯڸ Ʈ ӻ ۼȴ. EMA Űγ ڷγ19 ġμ ߰, ġü Կ ִ ȹ̴.
, Ʈ Ѹ 䡯 Űγ ż ǰ㰡 ϱ ̹ ǰ , ӻ ӻ EMA , CHMP 2 24Ϻ Ʈ Űγ ȿ ߴ.
Ʈ ۷ι ż Ϸ Ȱ Ȯ ϰ ִ. ̹ 10 Ϸ, ﰢ ֵ 信 150~300 Űγ ߰ ȹ̴.
ؼ (junsoo@mdtoday.co.kr)
<ǰ ̴ ѹα ǥ Ƿ, ǰ Ź , >
|
|
|
 |
|
|
|
|
|
 |
|
|
|
|
|
|
 |
|
- 뱸÷-̹ø, ̷ ȭ ȯ
- ѱ Ʈ, ڸ FDA ӻ 2 2ܰ 80 Ϸᡱ
- dz, ڷγ19 ġ 'Ƕƽ' ӻ 2
- ȭǰ, ġ ٸ ũ
- Ľ, ƿ 6 ȥչ ''
- Ƽ , ġ ߰
- ƼƮ, ̼ Ҽ 1 ġ 㰡
- ϵ, ѷϼƾ Ư
- ̿, Ϸ 'Ŭ' ġ
- Ѵ, 2DZũ븮 п ذ
|
|
|
|
    |
|
|
|
|